This inventor holds 1 USPTO granted patent. Top assignee: Suzhou Purevision Medical Technology Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations in Glaucoma Treatment by Xingyi Li
Introduction
Xingyi Li is an accomplished inventor based in Wenzhou, China, known for his significant contributions to medical technology. His innovative work focuses on developing solutions for glaucoma treatment, a condition that affects millions worldwide. With one patent to his name, Li is making strides in the field of ophthalmology.
Latest Patents
Xingyi Li's most notable patent is the "Inner drainage biomimetic stent for glaucoma and use thereof." This invention presents a method for manufacturing an inner drainage biomimetic stent designed specifically for glaucoma patients. The stent features a cylindrical tube body with a hollow structure, complemented by multiple straight tubes that support the tube wall. Proper placement of this stent allows for the smooth flow of aqueous humor through an orifice expanded by the stent, effectively re-expanding a collapsed Schlemm's canal. This innovative approach aims to lower intraocular pressure, thereby achieving effective glaucoma treatment.
Career Highlights
Li is currently employed at Suzhou Purevision Medical Technology Co., Ltd., where he continues to develop groundbreaking medical devices. His work is characterized by a commitment to improving patient outcomes through innovative technology.
Collaborations
Xingyi Li collaborates with talented professionals in his field, including Yuanbo Liang and Changcan Shi. These partnerships enhance the development and implementation of advanced medical solutions.
Conclusion
Xingyi Li's contributions to glaucoma treatment through his innovative biomimetic stent exemplify the potential of medical technology to improve lives. His work not only addresses a critical health issue but also showcases the importance of collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile